Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2005

View Archived Issues

Antipsychotic effects of a new 5-HT2C receptor agonist from Pfizer

Curcumin and its metabolite highlighted as promising agents for neurologic disorders

JNJ-27291199, an Hdm2:p53 complex inhibitor, potentiates doxorubicin

NSC-67657: A CEBPalpha activator with antileukemic potential

Tanabe updates pipeline progress in H1 FY2005

Oscient files Factive sNDA for five-day treatment of new indications

Pfizer exercises option to NicOx collaborative compounds

Myriad Genetics and Abbott extend pharmacogenetics alliance

First patient enrolled in European phase III trial of Alzhemed

Large multivalent immunogen vaccine active in melanoma, renal cell carcinoma

Tocilizumab study results reveal efficacy in arthritis, systemic lupus erythematosus

Golimumab improves signs and symptoms of refractory rheumatoid arthritis

Oral cFMS kinase inhibitor GW-2580 inhibits CSF-1 signaling in vivo

ALK5 inhibition attenuates profibrotic signaling and fibrogenic response

Flow-induced arterial remodeling modified by cavtratin

Novartis reports novel CCR1 antagonists with activity in experimental arthritis

Clevudine demonstrates sustained activity in chronic hepatitis B patients

Lassa fever vaccine candidate developed

ENMD-1198 to enter clinical testing in 2006

Emergent BioSolutions tests single dose oral typhoid vaccine in Vietnam

Genzyme acquires Cell Genesys' San Diego manufacturing operation

Phase IIb HCV study to evaluate celgosivir plus Pegetron

ChemoCentryx seeks clearance to begin clinical studies of CCX-915

Enrollment begins in phase III Viprinex study for ischemic stroke

Phase III Oxytrex results in moderate to severe osteoarthritic pain

Allergan proposes to acquire Inamed

Xyrem approved to treat excessive daytime sleepiness in narcolepsy patients

Approvable letter for Vasovist

Pexelizumab fails to meet primary endpoint threshold for statistical significance

Recent Merck KGaA patent claims novel anticoagulant agents

Cardiovascular agents disclosed in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...